SCHEMBL5726545

SCHEMBL5726545

COc1ccc2c(c1)nc(S)n2S(=O)(=O)c1c(C)cc(O)cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
TSHR P16473 2/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CYTH2 Q99418 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
RAD51 Q06609 1/20 0.38
USP2 O75604 1/20 0.38
GAA P10253 1/20 0.38
RECQL P46063 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ACSS2 Q9NR19 1/20 0.37
POLB P06746 1/20 0.37
HTR6 P50406 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 1/20 0.36
CXCL8 P10145 1/20 0.36
NOD1 Q9Y239 1/20 0.36
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5377800 0.84 TSHR (0.42) ALDH1A1TSHRLMNAHTTTDP1
SCHEMBL14356225 0.83 MAPK1 (0.39) ALDH1A1TSHRLMNAHTTTDP1
SCHEMBL6511360 0.83 TDP1 (0.43) ALDH1A1TSHRLMNAHTTTDP1
SCHEMBL14356239 0.76 SMN1; SMN2 (0.49) ALDH1A1TSHRSMN1; SMN2USP2GAA
SCHEMBL14356278 0.73 CXCL8 (0.44) ALDH1A1TSHRLMNAHTTTDP1
SCHEMBL5378083 0.73 RORC (0.35) ALDH1A1TSHRLMNAHTTGAA
SCHEMBL14387883 0.73 MAPK1 (0.48) ALDH1A1TSHRLMNASMN1; SMN2GAA
SCHEMBL5359147 0.73 CXCL8 (0.44) ALDH1A1TSHRLMNAHTTSMN1; SMN2
SCHEMBL5370928 0.70 ALDH1A1 (0.41) ALDH1A1TSHRLMNAHTTSMN1; SMN2
SCHEMBL5370451 0.70 CXCL8 (0.39) ALDH1A1TSHRLMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556371-B1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PRODRUGS OF PROTON PUMP INHIBITOR WINSTON PHARMACEUTICALS LLC (US) 2006-04-19 EP disclosed
EP-1644352-A1 PROCESS FOR PREPARING ISOMERICALLY PURE PRODRUGS OF PROTON PUMP INHIBITORS Allergan, Inc. (US) 2006-04-12 EP disclosed
WO-2005016917-A1 PROCESS FOR PREPARING ISOMERICALLY PURE PRODRUGS OF PROTON PUMP INHIBITORS ALLERGAN, INC. (US) 2005-02-24 WO disclosed